Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3892/mmr.2016.5770 http://scihub22266oqcxt.onion/10.3892/mmr.2016.5770 C5101903!5101903 !27666124     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27666124 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27666124 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Mol+Med+Rep 2016 ; 14 (5 ): 4135-4143 Nephropedia Template TP {{tp|p=27666124 |t=2016. miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1 |pdf=|usr=}}{{27666124 }} gab.com Text miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1 JO: Mol Med Rep http://www.kidney.de/pget.php?&tw=1&pmid=27666124 #FOAvip Crizotinib is an orally administered drug for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non?small cell lung cancer (NSCLC). Despite the impressive efficacy of crizotinib in the treatment of ALK?positive lung cancer, acquired resistance eventually develops in the majority of patients. The microRNA (miR)?200c reverses the resistance of lung cancer cells to various chemotherapeutic drugs and molecular targeted drugs, however, whether it can reverse the resistance of crizotinib remains unknown. The present study established a crizotinib resistant cell line (NCI?2228/CRI), which was derived from the parental NCI?2228 cell line by long?term exposure to increasing concentrations of crizotinib. Through overexpression and suppression of miR?200c expression, the characteristics associated with epithelial?mesenchymal transition (EMT), including morphology, EMT marker proteins and cellular mobility, were investigated. Cell viability and invasion assays demonstrated that high expression of miR?200c significantly inhibited the proliferation, migration and invasion of NCI?2228 cells compared with the negative control. A luciferase reporter assay indicated that miR?200c directly targeted the 3'?untranslated region of zinc finger E?box binding homeobox 1. Additionally, reverse transcription?quantitative polymerase chain reaction analysis demonstrated that the mRNA levels of N?cadherin and Vimentin were decreased in NCI?2228 cells transfected with miR?200c mimic compared with negative control cells, whereas the mRNA level of E?cadherin was increased. In addition, EMT was reversed by miR?200c, which suggests that miR?200c may serve a role in mediating the sensitivity of NCI?2228/CRI cells to crizotinib. The present study may therefore contribute to improving the sensitivity of ALK positive lung cancer cells to crizotinib. Twit Text FOAVip miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1 ????Mol Med Rep http://www.kidney.de/pget.php?&tw=1&pmid=27666124 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27666124 #FOAvip English Wikipedia <ref>{{Cite pmid|27666124 }}</ref> miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1 #MMPMID27666124 Gao HX ; Yan L ; Li C ; Zhao LM ; Liu W Mol Med Rep 2016[Nov]; 14 (5 ): 4135-4143 PMID27666124 show ga Crizotinib is an orally administered drug for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non?small cell lung cancer (NSCLC). Despite the impressive efficacy of crizotinib in the treatment of ALK?positive lung cancer, acquired resistance eventually develops in the majority of patients. The microRNA (miR)?200c reverses the resistance of lung cancer cells to various chemotherapeutic drugs and molecular targeted drugs, however, whether it can reverse the resistance of crizotinib remains unknown. The present study established a crizotinib resistant cell line (NCI?2228/CRI), which was derived from the parental NCI?2228 cell line by long?term exposure to increasing concentrations of crizotinib. Through overexpression and suppression of miR?200c expression, the characteristics associated with epithelial?mesenchymal transition (EMT), including morphology, EMT marker proteins and cellular mobility, were investigated. Cell viability and invasion assays demonstrated that high expression of miR?200c significantly inhibited the proliferation, migration and invasion of NCI?2228 cells compared with the negative control. A luciferase reporter assay indicated that miR?200c directly targeted the 3'?untranslated region of zinc finger E?box binding homeobox 1. Additionally, reverse transcription?quantitative polymerase chain reaction analysis demonstrated that the mRNA levels of N?cadherin and Vimentin were decreased in NCI?2228 cells transfected with miR?200c mimic compared with negative control cells, whereas the mRNA level of E?cadherin was increased. In addition, EMT was reversed by miR?200c, which suggests that miR?200c may serve a role in mediating the sensitivity of NCI?2228/CRI cells to crizotinib. The present study may therefore contribute to improving the sensitivity of ALK positive lung cancer cells to crizotinib. |Anaplastic Lymphoma Kinase [MESH] |Animals [MESH] |Carcinoma, Non-Small-Cell Lung/*drug therapy/genetics/pathology [MESH] |Cell Line, Tumor [MESH] |Cell Movement/drug effects [MESH] |Cell Proliferation/drug effects [MESH] |Crizotinib [MESH] |Drug Resistance, Neoplasm/genetics [MESH] |Epithelial-Mesenchymal Transition/genetics [MESH] |Gene Expression Regulation, Neoplastic [MESH] |Humans [MESH] |MicroRNAs/biosynthesis/*genetics [MESH] |Neoplasm Metastasis [MESH] |Pyrazoles/*administration & dosage [MESH] |Pyridines/*administration & dosage [MESH] |RNA, Messenger/genetics [MESH] |Receptor Protein-Tyrosine Kinases/*genetics [MESH]miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells(epmc).pdf DeepDyve Pubget Overpricing